iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN – Get Free Report)’s share price fell 0.5% during trading on Monday . The stock traded as low as $33.80 and last traded at $33.99. 556 shares changed hands during trading, a decline of 69% from the average session volume of 1,783 shares. The stock had previously closed at $34.15.
iShares Neuroscience and Healthcare ETF Stock Performance
The stock has a market cap of $5.09 million, a price-to-earnings ratio of 15.61 and a beta of 0.77. The company’s 50 day simple moving average is $34.54 and its 200 day simple moving average is $32.87.
About iShares Neuroscience and Healthcare ETF
The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap. IBRN was launched on Aug 24, 2022 and is managed by BlackRock.
Read More
- Five stocks we like better than iShares Neuroscience and Healthcare ETF
- Everpure: AI Storage Uncertainty Overshadows Breakneck Growth
- This Tech ETF Is Beating QQQ—and Canada May Be Part of the Reason
- Intel Is the Market’s Most Mispriced AI Hedge
- The Biggest Opportunity From SpaceX’s IPO May Surprise You
Receive News & Ratings for iShares Neuroscience and Healthcare ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Neuroscience and Healthcare ETF and related companies with MarketBeat.com's FREE daily email newsletter.
